Lyndsay N. Harris
0000-0002-9774-6719
Publication & Citation Trends
Publications
478 total
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Cited by 811
OpenAlex
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840 PDF
Cited by 602
OpenAlex
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
Cited by 2,212
OpenAlex
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
Cited by 1,208
OpenAlex
Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer PDF
Cited by 1,106
OpenAlex
Research Topics
Cancer Genomics and Diagnostics
(144)
HER2/EGFR in Cancer Research
(137)
Lung Cancer Treatments and Mutations
(102)
Breast Cancer Treatment Studies
(83)
Colorectal Cancer Treatments and Studies
(79)
Affiliations
Rutgers, The State University of New Jersey
Cleveland State University
Boston University
University of Vermont
University of North Carolina at Chapel Hill